Skip to content
Skip to navigation menu
20 July 2010
A new test to help reduce the stress and time patients have wait to find out if treatment for bladder cancer has been successful is set to be developed as part of a new University collaboration.
Morvus Technology Limited has joined forces with Professors Ian Weeks and Howard Kynaston from the School of Medicine and Cardiff and Vale University Health Board to research and develop a new rapid diagnostic test for genitourinary cancers.
The project will harness over 25 years of University expertise in the development of innovative diagnostic tests and cancer treatment.
Professor Ian Weeks, based in the School of Medicine’s Department of Infection, Immunity and Biochemistry, is a leading figure in diagnostic research has worked on developing a number of successful diagnostic tests. Professor Howard Kynaston is one of the UK’s leading experts in urological cancers.
Professor Ian Weeks, School of Medicine said: "There is a clear need for a rapid, non-invasive diagnostic test for recurrent bladder cancer. Such a test will be less burdensome to patients and will considerably reduce costs to the healthcare system."
The project is funded by a £74,550 grant from the National Institute for Health Research’s i4i programme.
Dr Phil Burke, Chief Executive Officer of Morvus added: "This work will address an area of unmet medical need and is potentially capable of making a significant difference to the lives of many cancer patients."
The children’s champion
Canadian company acquires Cardiff engineering spin-out Mesuro
Welsh think tank marks a successful first year
World Cup ref blows the whistle on mental health
Multi-billion dollar industry with power to transform developing countries
Developing project managers
Common ground discovered in mental illness
Leading microbiologist warns of killer fungi’s increasing threat
This is an externally hosted beta service offered by Google.